2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-phenyl-1,3-thiazole;2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-thiazole;2-[3-[3-(3-methyl-2H-imidazol-2-id-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-phenyl-1,3-thiazole;2-[3-[3-(1-methylimidazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-phenyl-1,3-thiazole;2-[3-[3-(1-methylimidazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-thiazole;platinum;tetrakis(platinum(2+))

C125H88N17O5Pt5S5-3 — CID 160896757

About 2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-phenyl-1,3-thiazole;2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-thiazole;2-[3-[3-(3-methyl-2H-imidazol-2-id-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-phenyl-1,3-thiazole;2-[3-[3-(1-methylimidazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-phenyl-1,3-thiazole;2-[3-[3-(1-methylimidazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-thiazole;platinum;tetrakis(platinum(2+))

2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-phenyl-1,3-thiazole;2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-thiazole;2-[3-[3-(3-methyl-2H-imidazol-2-id-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-phenyl-1,3-thiazole;2-[3-[3-(1-methylimidazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-phenyl-1,3-thiazole;2-[3-[3-(1-methylimidazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-thiazole;platinum;tetrakis(platinum(2+)) (PubChem CID 160896757) has the molecular formula C125H88N17O5Pt5S5-3 and a molecular weight of 3043.92 g/mol. Its IUPAC name is 2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-phenyl-1,3-thiazole;2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-thiazole;2-[3-[3-(3-methyl-2H-imidazol-2-id-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-phenyl-1,3-thiazole;2-[3-[3-(1-methylimidazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-phenyl-1,3-thiazole;2-[3-[3-(1-methylimidazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-thiazole;platinum;tetrakis(platinum(2+)).

Molecular Properties

• Compound Name: 2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-phenyl-1,3-thiazole;2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-thiazole;2-[3-[3-(3-methyl-2H-imidazol-2-id-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-phenyl-1,3-thiazole;2-[3-[3-(1-methylimidazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-phenyl-1,3-thiazole;2-[3-[3-(1-methylimidazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-thiazole;platinum;tetrakis(platinum(2+))
• PubChem CID: 160896757
• Molecular Formula: C125H88N17O5Pt5S5-3
• Molecular Weight: 3043.92 g/mol
• Exact Mass: 3041.40
• IUPAC Name: 2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-phenyl-1,3-thiazole;2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-thiazole;2-[3-[3-(3-methyl-2H-imidazol-2-id-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-phenyl-1,3-thiazole;2-[3-[3-(1-methylimidazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-phenyl-1,3-thiazole;2-[3-[3-(1-methylimidazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-thiazole;platinum;tetrakis(platinum(2+))
• SMILES: CN1C=CN(c2[c-]c(Oc3[c-]c(-c4ncc(-c5ccccc5)s4)ccc3)ccc2)[CH-]1.Cc1cc(C)n(-c2[c-]c(Oc3[c-]c(-c4ncc(-c5ccccc5)s4)ccc3)ccc2)n1.Cc1cc(C)n(-c2[c-]c(Oc3[c-]c(-c4ncc(-c5cccnc5)s4)ccc3)ccc2)n1.Cn1ccnc1-c1[c-]c(Oc2[c-]c(-c3ncc(-c4ccccc4)s3)ccc2)ccc1.Cn1ccnc1-c1[c-]c(Oc2[c-]c(-c3ncc(-c4cccnc4)s3)ccc2)ccc1.[Pt+2].[Pt+2].[Pt+2].[Pt+2].[Pt]
• InChI: InChI=1S/C26H19N3OS.C25H18N4OS.C25H18N3OS.C25H17N3OS.C24H16N4OS.5Pt/c1-18-14-19(2)29(28-18)22-11-7-13-24(16-22)30-23-12-6-10-21(15-23)26-27-17-25(31-26)20-8-4-3-5-9-20;1-17-12-18(2)29(28-17)21-8-4-10-23(14-21)30-22-9-3-6-19(13-22)25-27-16-24(31-25)20-7-5-11-26-15-20;1-27-13-14-28(18-27)21-10-6-12-23(16-21)29-22-11-5-9-20(15-22)25-26-17-24(30-25)19-7-3-2-4-8-19;1-28-14-13-26-24(28)19-9-5-11-21(15-19)29-22-12-6-10-20(16-22)25-27-17-23(30-25)18-7-3-2-4-8-18;1-28-12-11-26-23(28)17-5-2-8-20(13-17)29-21-9-3-6-18(14-21)24-27-16-22(30-24)19-7-4-10-25-15-19;;;;;/h3-14,17H,1-2H3;3-12,15-16H,1-2H3;2-14,17-18H,1H3;2-14,17H,1H3;2-12,15-16H,1H3;;;;;/q2*-2;-3;2*-2;;4*+2
• InChIKey: FCGAFDZCJYFGFB-UHFFFAOYSA-N
• XLogP: 30.87
• TPSA: 214.14 Ų
• H-Bond Acceptors: 27
• Rotatable Bonds: 25
• Heavy Atoms: 157
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	3043.92
LogP ≤ 5	30.87
H-Bond Donors ≤ 5	0
H-Bond Acceptors ≤ 10	27

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of 2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-phenyl-1,3-thiazole;2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-thiazole;2-[3-[3-(3-methyl-2H-imidazol-2-id-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-phenyl-1,3-thiazole;2-[3-[3-(1-methylimidazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-phenyl-1,3-thiazole;2-[3-[3-(1-methylimidazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-thiazole;platinum;tetrakis(platinum(2+))?

The IUPAC name of 2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-phenyl-1,3-thiazole;2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-thiazole;2-[3-[3-(3-methyl-2H-imidazol-2-id-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-phenyl-1,3-thiazole;2-[3-[3-(1-methylimidazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-phenyl-1,3-thiazole;2-[3-[3-(1-methylimidazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-thiazole;platinum;tetrakis(platinum(2+)) (CID 160896757) is 2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-phenyl-1,3-thiazole;2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-thiazole;2-[3-[3-(3-methyl-2H-imidazol-2-id-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-phenyl-1,3-thiazole;2-[3-[3-(1-methylimidazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-phenyl-1,3-thiazole;2-[3-[3-(1-methylimidazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-thiazole;platinum;tetrakis(platinum(2+)).

What is the SMILES notation for 2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-phenyl-1,3-thiazole;2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-thiazole;2-[3-[3-(3-methyl-2H-imidazol-2-id-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-phenyl-1,3-thiazole;2-[3-[3-(1-methylimidazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-phenyl-1,3-thiazole;2-[3-[3-(1-methylimidazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-thiazole;platinum;tetrakis(platinum(2+))?

The canonical SMILES for 2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-phenyl-1,3-thiazole;2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-thiazole;2-[3-[3-(3-methyl-2H-imidazol-2-id-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-phenyl-1,3-thiazole;2-[3-[3-(1-methylimidazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-phenyl-1,3-thiazole;2-[3-[3-(1-methylimidazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-thiazole;platinum;tetrakis(platinum(2+)) is CN1C=CN(c2[c-]c(Oc3[c-]c(-c4ncc(-c5ccccc5)s4)ccc3)ccc2)[CH-]1.Cc1cc(C)n(-c2[c-]c(Oc3[c-]c(-c4ncc(-c5ccccc5)s4)ccc3)ccc2)n1.Cc1cc(C)n(-c2[c-]c(Oc3[c-]c(-c4ncc(-c5cccnc5)s4)ccc3)ccc2)n1.Cn1ccnc1-c1[c-]c(Oc2[c-]c(-c3ncc(-c4ccccc4)s3)ccc2)ccc1.Cn1ccnc1-c1[c-]c(Oc2[c-]c(-c3ncc(-c4cccnc4)s3)ccc2)ccc1.[Pt+2].[Pt+2].[Pt+2].[Pt+2].[Pt].

What is the InChIKey of 2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-phenyl-1,3-thiazole;2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-thiazole;2-[3-[3-(3-methyl-2H-imidazol-2-id-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-phenyl-1,3-thiazole;2-[3-[3-(1-methylimidazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-phenyl-1,3-thiazole;2-[3-[3-(1-methylimidazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-thiazole;platinum;tetrakis(platinum(2+))?

The InChIKey is FCGAFDZCJYFGFB-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H19N3OS.C25H18N4OS.C25H18N3OS.C25H17N3OS.C24H16N4OS.5Pt/c1-18-14-19(2)29(28-18)22-11-7-13-24(16-22)30-23-12-6-10-21(15-23)26-27-17-25(31-26)20-8-4-3-5-9-20;1-17-12-18(2)29(28-17)21-8-4-10-23(14-21)30-22-9-3-6-19(13-22)25-27-16-24(31-25)20-7-5-11-26-15-20;1-27-13-14-28(18-27)21-10-6-12-23(16-21)29-22-11-5-9-20(15-22)25-26-17-24(30-25)19-7-3-2-4-8-19;1-28-14-13-26-24(28)19-9-5-11-21(15-19)29-22-12-6-10-20(16-22)25-27-17-23(30-25)18-7-3-2-4-8-18;1-28-12-11-26-23(28)17-5-2-8-20(13-17)29-21-9-3-6-18(14-21)24-27-16-22(30-24)19-7-4-10-25-15-19;;;;;/h3-14,17H,1-2H3;3-12,15-16H,1-2H3;2-14,17-18H,1H3;2-14,17H,1H3;2-12,15-16H,1H3;;;;;/q2*-2;-3;2*-2;;4*+2.

What are the key properties of 2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-phenyl-1,3-thiazole;2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-thiazole;2-[3-[3-(3-methyl-2H-imidazol-2-id-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-phenyl-1,3-thiazole;2-[3-[3-(1-methylimidazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-phenyl-1,3-thiazole;2-[3-[3-(1-methylimidazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-thiazole;platinum;tetrakis(platinum(2+))?

2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-phenyl-1,3-thiazole;2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-thiazole;2-[3-[3-(3-methyl-2H-imidazol-2-id-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-phenyl-1,3-thiazole;2-[3-[3-(1-methylimidazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-phenyl-1,3-thiazole;2-[3-[3-(1-methylimidazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-thiazole;platinum;tetrakis(platinum(2+)) has a molecular weight of 3043.92 g/mol, XLogP of 30.87, 25 rotatable bonds, 0 hydrogen bond donors, and 27 hydrogen bond acceptors.

Where does this data come from?

All data for 2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-phenyl-1,3-thiazole;2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-thiazole;2-[3-[3-(3-methyl-2H-imidazol-2-id-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-phenyl-1,3-thiazole;2-[3-[3-(1-methylimidazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-phenyl-1,3-thiazole;2-[3-[3-(1-methylimidazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-thiazole;platinum;tetrakis(platinum(2+)) is sourced from PubChem (CID 160896757), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).